Spots Global Cancer Trial Database for pancreatic cancer stage iii
Every month we try and update this database with for pancreatic cancer stage iii cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer | NCT04137822 | Pancreas Cancer Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... | IMM-101 | 18 Years - | Impatients N.V. trading as myTomorrows | |
Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III) | NCT01065870 | Pancreatic Canc... Pancreatic Canc... | Neoadjuvant gem... Gemcitabine, ca... | 18 Years - | Columbia University | |
Pancreatic Cancer Detection Consortium | NCT06388967 | Pancreatic Canc... Pancreatic Carc... Pancreatic Aden... Pancreatic Duct... Pancreatic Neop... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... | PANcreatic canc... | 18 Years - | City of Hope Medical Center | |
Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III) | NCT01065870 | Pancreatic Canc... Pancreatic Canc... | Neoadjuvant gem... Gemcitabine, ca... | 18 Years - | Columbia University | |
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer | NCT04406831 | Pancreatic Canc... Pancreatic Canc... Pancreatic Duct... Pancreatic Neop... | Blood draw | 18 Years - | Nuvance Health | |
Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients With Unresectable Pancreatic Cancer. | NCT03252808 | Pancreatic Canc... Pancreatic Canc... | TBI-1401(HF10) Gemcitabine Nab-paclitaxel TS-1 | 20 Years - | Takara Bio Inc. | |
Pancreatic Cancer Detection Consortium | NCT06388967 | Pancreatic Canc... Pancreatic Carc... Pancreatic Aden... Pancreatic Duct... Pancreatic Neop... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... | PANcreatic canc... | 18 Years - | City of Hope Medical Center | |
Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer | NCT03236883 | Pancreatic Canc... Pancreatic Canc... | Gemcitabine GPBSC | 18 Years - 80 Years | Tianjin Medical University Cancer Institute and Hospital | |
Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer | NCT04137822 | Pancreas Cancer Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... | IMM-101 | 18 Years - | Impatients N.V. trading as myTomorrows | |
Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer | NCT05562297 | Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... | sintilimab nab-paclitaxel gemcitabine | 18 Years - 75 Years | Shanghai Zhongshan Hospital |